From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

The partnership, which began in December 2022, now provides AbbVie access to AbCellera’s TCE platform for the development of therapeutic antibodies targeting tumours. AbbVie will have the rights ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

Traditional methods for identifying therapeutic antibodies are not ... accelerated timelines for identification and further development of antibodies for HIV, Ebola, and influenza in recent ...

The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several ...

In this article, we are going to take a look at where ImmunoPrecise Antibodies Ltd. (NASDAQ ... said that the company anticipates enabling the development of three key robots in the coming years ...

The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...

Akeso, Inc. (9926. HK) ('Akeso' or the 'Company') is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) ...